Skip to content
OpenCapital
Get started

LENZ Therapeutics, Inc. LENZ Q1 2025 earnings

Reported May 7, 2025 · After market close

EPS-$0.53Beat by $0.02
EPS estimate-$0.55

Next report

Jul 29, 2026 (Today)
Revenue estimate$2.4M
EPS estimate-$1.05

Versus estimates

Revenue

Q1 2026$1.9MBeat by $142.1KQ4 2025$1.6MMiss by $1.5MQ3 2025$12.5MBeat by $9.5MQ2 2025$5.0MBeat by $4.3M

Diluted EPS

Q1 2026-$1.32Miss by $0.22Q4 2025-$1.16Miss by $0.25Q3 2025-$0.59Beat by $0.08Q2 2025-$0.53Beat by $0.05
Q1 2025-$0.53Beat by $0.02
Q4 2024-$0.46Miss by $0.04

Ask the moment LENZ Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did LENZ Therapeutics, Inc. report Q1 2025 earnings?
LENZ Therapeutics, Inc. (LENZ) reported Q1 2025 earnings on May 7, 2025 after market close.
What were LENZ Therapeutics, Inc.'s Q1 2025 revenue and EPS?
LENZ Therapeutics, Inc. reported eps of $-0.53 for Q1 2025.
Did LENZ Therapeutics, Inc. beat estimates in Q1 2025?
EPS beat the consensus estimate of $-0.55 by $0.02.
How did LENZ Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 85.0% from $-3.53.
Where can I find LENZ Therapeutics, Inc.'s Q1 2025 SEC filings?
You can read the 10-Q periodic report (0001815776-25-000032) directly on SEC EDGAR. The filing index links above go to sec.gov.